Importantly, countries that have had a historically low burden of CVD disease, such as Switzerland and Japan, have still managed to make substantial gains. This suggests not only that other countries can also make further gains, but also raises important questions about why success has varied so much across countries. All countries have been successful in improving life expectancy at birth and at age 65. In percentage terms, life expectancy has improved even more once a person reaches 65 years of age.